148 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Seidman
    Seidman
  4. Zelenetz
    Zelenetz
  5. Kelsen
    Kelsen
  6. Moskowitz
    Moskowitz
  7. Noy
    Noy
  8. Panageas
    Panageas
  9. Hensley
    Hensley
  10. Moore
    Moore

Groups

  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (70)
  3. Hematologic Malignancies, Division of (39)
  4. Survivorship Research (37)
  5. Breast Medicine Service (32)
  6. Center for Hematologic Malignancies (30)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (28)
  8. Biostatistics Service (26)
  9. Epidemiology and Biostatistics (26)
  10. Nursing (19)
  1. "recombinant granulocyte colony stimulating factor"
Formats
  1. Journal Article (143)
  2. Conference Paper (5)
Groups
  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (70)
  3. Hematologic Malignancies, Division of (39)
  4. Survivorship Research (37)
  5. Breast Medicine Service (32)
  6. Center for Hematologic Malignancies (30)

More Groups

People
  1. Clifford Hudis (19)
  2. Larry Norton (19)
  3. Andrew Seidman (14)
  4. Andrew Zelenetz (12)
  5. Craig Moskowitz (10)
  6. David Kelsen (10)

More People

Years
  1. 2024 (1)
  2. 2015 (2)
  3. 2014 (3)
  4. 2013 (4)
  5. 2012 (5)
  6. 2011 (10)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Cancer (14)
  3. Clinical Breast Cancer (6)
  4. Seminars in Oncology (6)
  5. Blood (5)
  6. Gynecologic Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (31)
  2. Elsevier Inc. (27)
  3. Wiley Blackwell (16)
  4. Springer (11)
  5. Oxford University Press (9)
  6. Nature Publishing Group (7)

More Publishers

Results (148)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of extraosseous extramedullary disease on outcomes of patients with relapsed-refractory multiple myeloma receiving standard-of-care chimeric antigen receptor T-cell therapy
    Journal Article

    Dima, D.; Abdallah, A. O.; Davis, J. A.; Awada, H.; Goel, U.; Rashid, A.; DeJarnette, S.; Anwer, F.; Shune, L.; Raza, S.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Randomized multicenter phase II study of modified docetaxel, cisplatin, and fluorouracil (DCF) versus DCF plus growth factor support in patients with metastatic gastric adenocarcinoma: A study of the US gastric cancer consortium
    Journal Article

    Shah, M. A.; Janjigian, Y. Y.; Stoller, R.; Shibata, S.; Kemeny, M.; Krishnamurthi, S.; Bernard, Su, Y.; Ocean, A.; Capanu, M.; Mehrotra, B.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The addition of granulocyte-colony stimulating factor shifts the dose limiting toxicity and markedly increases the maximum tolerated dose and activity of the kinesin spindle protein inhibitor SB-743921 in patients with relapsed or refractory lymphoma: Results of an international, multicenter phase I/II study
    Journal Article

    O'Connor, O. A.; Gerecitano, J.; Van Deventer, H.; Hainsworth, J.; Zullo, K. M.; Saikali, K.; Seroogy, J.; Wolff, A.; EscandoĢn, R.
    Leukemia and Lymphoma (2015)

    Fulltext@MSK | Save
  • Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: Pathologic, radiologic, and biomarker correlates
    Journal Article

    Choueiri, T. K.; Jacobus, S.; Bellmunt, J.; Qu, A.; Appleman, L. J.; Tretter, C.; Bubley, G. J.; Stack, E. C.; Signoretti, S.; Walsh, M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • High-dose cyclophosphamide for the treatment of refractory T-cell acute lymphoblastic leukemia in children
    Journal Article

    Kobos, R.; Shukla, N.; Renaud, T.; Prockop, S. E.; Boulad, F.; Steinherz, P. G.
    Journal of Pediatric Hematology/Oncology (2014)

    Fulltext@MSK | Save
  • A Phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with BCell lymphoid malignancies: Favorably durable event-free survival in chemosensitive patients
    Journal Article

    Sauter, C. S.; Barker, J. N.; Lechner, L.; Zheng, J.; Devlin, S. M.; Papadopoulos, E. B.; Perales, M. A.; Jakubowski, A. A.; Goldberg, J. D.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer
    Journal Article

    Seidman, A. D.; Conlin, A. K.; Bach, A.; Moynahan, M. E.; Lake, D.; Forero, A.; Wright, G. S.; Hackney, M. H.; Clawson, A.; Norton, L.; more...
    Clinical Breast Cancer (2013)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers
    Journal Article

    Chaft, J. E.; Rusch, V.; Ginsberg, M. S.; Paik, P. K.; Finley, D. J.; Kris, M. G.; Price, K. A. R.; Azzoli, C. G.; Fury, M. G.; Riely, G. J.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: Results of a phase 2 trial (SARC 005)
    Journal Article

    Hensley, M. L.; Wathen, J. K.; Maki, R. G.; Araujo, D. M.; Sutton, G.; Priebat, D. A.; George, S.; Soslow, R. A.; Baker, L. H.
    Cancer (2013)

    Fulltext@MSK | Save
  • Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS malignancy consortium study 047
    Journal Article

    Levine, A. M.; Noy, A.; Lee, J. Y.; Tam, W.; Ramos, J. C.; Henry, D. H.; Parekh, S.; Reid, E. G.; Mitsuyasu, R.; Cooley, T.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save